Clinical Trials
31 trialsPhase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
M.D. Anderson Cancer Center
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
M.D. Anderson Cancer Center
PRIMO
Gustave Roussy, Cancer Campus, Grand Paris
TAX-TORC
Royal Marsden NHS Foundation Trust
ComPAKT
Royal Marsden NHS Foundation Trust
A Study Explore JS001+JS002 in Patients With Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
University Health Network, Toronto
JS001+IMP4297 in Patients With Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
M.D. Anderson Cancer Center
LeY-CAR-T
Peter MacCallum Cancer Centre, Australia
FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib
M.D. Anderson Cancer Center
Bevacizumab in Multiple Phase I Combinations
M.D. Anderson Cancer Center
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer
M.D. Anderson Cancer Center
Treatment of Carrying TP53 Harmful Mutations
Tianjin Medical University Second Hospital
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
Hangzhou Cancer Hospital
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
M.D. Anderson Cancer Center
Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
University of Chicago
Sirolimus and Cetuximab in Advanced Malignancies
M.D. Anderson Cancer Center
Bendamustine and Bevacizumab for Advanced Cancers
M.D. Anderson Cancer Center
Docetaxel and Sirolimus in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Study of Erlotinib in Combination With Dasatinib
M.D. Anderson Cancer Center
Valproic Acid and Bevacizumab in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Randomized Controlled Trial of the Meaning-Making Intervention (MMi)
Jewish General Hospital
Rapamycin in Advanced Cancers
University of Chicago
Study of Rapamycin Plus Ketoconazole in Advanced Cancers
University of Chicago
Gemcitabine and Dasatinib in Advanced Solid Tumors
M.D. Anderson Cancer Center
Study of Temsirolimus, Topotecan, and Bortezomib
M.D. Anderson Cancer Center
STAT3 Inhibitor for Solid Tumors
M.D. Anderson Cancer Center
Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement
M.D. Anderson Cancer Center
Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement
M.D. Anderson Cancer Center